
  
    
      
        Background_NNP
        Recent_JJ reports_NNS describe_VBP the_DT use_NN of_IN gene-expression_JJ
        profiling_VBG for_IN the_DT identification_NN of_IN molecular_JJ markers_NNS of_IN
        toxicity_NN [_NN 1_CD 2_CD 3_CD ]_NN ._. This_DT technique_NN alone_RB does_VBZ not_RB account_VB
        for_IN morphological_JJ changes_NNS in_IN tissues_NNS that_WDT have_VBP
        traditionally_RB been_VBN used_VBN by_IN pathologists_NNS to_TO discriminate_JJ
        between_IN types_NNS and_CC severity_NN of_IN toxicological_JJ responses_NNS [_NN 4_CD 5_CD
        6_CD ]_NN ._. For_IN a_DT comprehensive_JJ approach_NN to_TO toxicological_JJ
        evaluation_NN ,_, we_PRP developed_VBD a_DT unique_JJ methodology_NN that_WDT uses_VBZ
        histomorphometric_JJ profiles_NNS ,_, derived_VBN from_IN machine_NN vision_NN ,_, in_IN
        conjunction_NN with_IN gene-expression_JJ profiles_NNS ,_, termed_VBD
        extensible_JJ morphometric_JJ relational_NN gene-expression_JJ analysis_NN
        (_( EMeRGE_NNP )_) ._. This_DT novel_NN method_NN was_VBD evaluated_VBN on_IN an_DT
        established_VBN ,_, extreme_JJ model_NN of_IN liver_NN toxicity_NN using_VBG carbon_NN
        tetrachloride_NN (_( CCl_NNP 
        4_LS )_) in_IN rats_NNS that_WDT were_VBD dosed_JJ for_IN 3_CD days_NNS
        and_CC allowed_VBN to_TO recover_VB ._. Liver_NNP is_VBZ relevant_JJ in_IN toxicology_NN as_IN
        the_DT primary_JJ organ_NN of_IN metabolism_NN and_CC detoxification_NN ;_: it_PRP is_VBZ a_DT
        recurrent_JJ target_NN of_IN chronic_JJ drug_NN toxicity_NN ._.
        A_DT fully_RB automated_VBN analytical_JJ microscope_NN equipped_VBN with_IN
        machine-vision_JJ hardware_NN and_CC software_NN was_VBD used_VBN to_TO generate_VB
        quantitative_JJ information_NN about_IN the_DT structure_NN and_CC
        heterogeneity_NN of_IN liver_NN ._. The_DT histomorphometric_JJ profiles_NNS
        could_MD be_VB used_VBN to_TO evaluate_VB tissue_NN heterogeneity_NN across_IN the_DT
        tissue_NN including_VBG regions_NNS of_IN hepatocellular_NN necrosis_NNS ._.
        Representative_NNP images_NNS of_IN tissue_NN sections_NNS from_IN control_NN and_CC
        treated_VBN tissues_NNS are_VBP shown_VBN in_IN Figure_NN 1_CD ._. Examples_NNS of_IN
        processed_VBN sample_NN image_NN tiles_NNS are_VBP shown_VBN in_IN Figure_NN 2_CD ,_, where_WRB a_DT
        control_NN liver_NN (_( Figure_NN 2_CD a_DT )_) can_MD be_VB compared_VBN to_TO a_DT treated_VBN
        liver_NN (_( Figure_NN 2_CD b_SYM )_) ,_, illustrating_VBG the_DT significant_JJ structural_JJ
        damage_NN induced_VBN by_IN treatment_NN with_IN CCl_NNP 
        4_CD ._. Gene-expression_NNP profiles_NNS were_VBD
        generated_VBN from_IN the_DT same_JJ livers_NNS using_VBG DNA_NNP microarrays_NNS ._. The_DT
        microarrays_NNS measured_VBD mRNA_NN transcription_NN levels_NNS of_IN genes_NNS
        important_JJ in_IN adsorption_NN ,_, distribution_NN ,_, metabolism_NN and_CC
        excretion_NN (_( ADME_NNP )_) ._. Previous_JJ studies_NNS of_IN these_DT genes_NNS ,_,
        including_VBG markers_NNS of_IN toxic_JJ stress_NN ,_, apoptosis_NNS ,_, growth_NN
        regulation_NN and_CC repair_NN ,_, were_VBD consistent_JJ with_IN documented_VBN
        toxicologic_JJ responses_NNS to_TO CCl_NNP 
        4_CD ,_, where_WRB expression_NN of_IN components_NNS of_IN
        cytochrome_NN P_NN 450_CD and_CC other_JJ metabolic_JJ enzymes_NNS (_( Cyp_NNP 2_CD C_NNP ,_,
        Cyp_NNP 3_CD A_DT 18_CD ,_, Cyp_NNP 3_CD A_DT 9_CD ,_, SCS_NNP and_CC Fmo_NNP 1_LS )_) were_VBD found_VBN to_TO decrease_VB ,_,
        whereas_IN certain_JJ genes_NNS involved_VBN in_IN the_DT inflammatory_JJ response_NN
        and_CC signal_NN transduction_NN were_VBD increased_VBN (_( CD_NNP 44_CD and_CC Lgals_NNP 3_LS )_) [_NN
        7_CD ]_NN ._.
        Previous_JJ studies_NNS relating_VBG gene_NN expression_NN to_TO pathologic_JJ
        or_CC tissue_NN data_NNS have_VBP evaluated_VBN qualitative_JJ tissue_NN
        information_NN only_RB [_NN 8_CD 9_CD ]_NN ,_, or_CC focused_VBD on_IN visually_RB
        identified_VBN tissue_NN subareas_NNS or_CC specific_JJ cells_NNS isolated_VBN by_IN by_IN
        laser_NN microdissection_NN (_( LMD_NNP )_) [_NN 10_CD 11_CD 12_CD ]_NN ._. In_IN LMD_NNP ,_, specific_JJ
        cells_NNS from_IN a_DT sample_NN are_NN collected_VBN by_IN interactively_RB defining_VBG
        areas_NNS of_IN interest_NN in_IN a_DT microscope_NN image_NN ,_, which_WDT are_VBP excised_VBN
        by_IN a_DT laser_NN for_IN subsequent_JJ gene-expression_JJ analysis_NN ._. LMD_NNP is_VBZ
        subjective_JJ and_CC destructive_JJ to_TO the_DT specimen_NN and_CC has_VBZ limited_VBN
        ability_NN to_TO account_VB for_IN tissue_NN heterogeneity_NN ._. Progress_NNP in_IN
        digital_JJ microscopy_NN has_VBZ allowed_VBN quantitative_JJ image_NN analysis_NN
        to_TO generate_VB data_NNS that_WDT objectively_RB and_CC completely_RB describe_VB
        tissue_NN phenotype_NN ,_, free_JJ of_IN observer_NN disagreement_NN [_NN 13_CD ]_NN ,_,
        and_CC with_IN the_DT potential_NN to_TO detect_VB subtle_JJ changes_NNS that_WDT are_VBP
        undetectable_JJ to_TO the_DT human_JJ eye_NN [_NN 14_CD ]_NN ._. Tissue_NNP
        histomorphometric_JJ profiles_NNS in_IN EMeRGE_NNP are_VBP correlated_JJ
        statistically_RB with_IN gene-expression_JJ profiles_NNS ,_, characterizing_VBG
        each_DT sample_NN through_IN both_DT top-down_JJ phenotypic_JJ information_NN
        and_CC complementary_JJ bottom-up_JJ genomic_JJ data_NNS ._. Spearman_NNP 's_POS rank_NN
        order_NN correlation_NN determined_VBD significant_JJ monotonic_JJ
        relationships_NNS that_WDT illuminate_VB important_JJ connections_NNS between_IN
        structural_JJ features_NNS in_IN tissue_NN elements_NNS and_CC genes_NNS that_WDT have_VBP
        been_VBN reported_VBN as_RB significantly_RB up-_NN or_CC downregulated_JJ by_IN CCl_NNP 
        4_CD treatment_NN in_IN previous_JJ studies_NNS [_NN 7_CD ]_NN ._.
        Principal_NN component_NN analysis_NN (_( PCA_NNP )_) ,_, as_IN described_VBN in_IN
        Materials_NNPS and_CC methods_NNS ,_, was_VBD carried_VBN out_IN to_TO reduce_VB the_DT
        complexity_NN of_IN the_DT data_NNS [_NN 15_CD ]_NN and_CC then_RB to_TO relate_VB individual_JJ
        animals_NNS to_TO specific_JJ phenotypic_JJ groups_NNS ._. A_DT quadratic_JJ
        regression_NN classifier_NN was_VBD used_VBN to_TO develop_VB a_DT scheme_NN that_WDT
        defined_VBD treated_VBN and_CC control_NN groups_NNS in_IN three_CD datasets_NNS :_: gene_NN
        expression_NN ,_, tissue_NN feature_NN and_CC the_DT combination_NN of_IN both_DT ._.
        This_DT method_NN required_VBD no_DT pre-selection_JJ or_CC filtering_VBG of_IN
        invariantly_RB expressing_VBG genes_NNS to_TO classify_VB groups_NNS as_RB
        previously_RB published_VBN ._. Although_IN the_DT classification_NN ability_NN
        was_VBD not_RB improved_VBN when_WRB tissue_NN features_NNS were_VBD added_VBN to_TO gene_NN
        expression_NN ,_, analysis_NN of_IN the_DT combined_VBN data_NN revealed_VBD
        different_JJ outlier_NN animals_NNS for_IN each_DT dataset_NN ,_, presenting_VBG a_DT
        more_RBR complete_JJ picture_NN of_IN the_DT damage_NN and_CC regeneration_NN ._.
      
      
        Results_NNS and_CC discussion_NN
        
          Correlation_NNP between_IN tissue_NN features_NNS and_CC gene_NN
          expression_NN
          Relationships_NNPS between_IN gene_NN expression_NN and_CC tissue_NN
          features_NNS can_MD be_VB a_DT deep_JJ source_NN of_IN information_NN about_IN toxin_NN
          mechanism_NN ._. Using_VBG Spearman_NNP 's_POS rank_NN order_NN correlation_NN (_( see_VB
          Materials_NNPS and_CC methods_NNS )_) ,_, we_PRP tested_VBD for_IN monotonic_JJ
          functional_JJ relationships_NNS between_IN gene-expression_JJ values_NNS
          and_CC tissue_NN features_NNS ._. The_DT numbers_NNS of_IN significant_JJ
          correlations_NNS were_VBD determined_VBN at_IN the_DT following_JJ levels_NNS :_:
          0_CD ._. 05_CD ,_, 0_CD ._. 01_CD and_CC 0_CD ._. 001_CD (_( Table_NNP 1_LS )_) ._. These_DT levels_NNS represent_VBP
          the_DT cutoff_NN probability_NN of_IN making_VBG a_DT type_NN I_PRP error_NN ,_, for_IN
          example_NN ,_, the_DT probability_NN of_IN determining_VBG that_IN there_EX exists_VBZ
          a_DT true_JJ correlation_NN when_WRB in_IN reality_NN there_EX is_VBZ none_NN ._.
          Genes_NNP that_IN correlated_JJ with_IN tissue_NN features_NNS with_IN a_DT 
          p_NN -_: value_NN of_IN 0_CD ._. 01_CD or_CC lower_JJR were_VBD
          chosen_VBN for_IN additional_JJ inspection_NN (_( see_VB Additional_JJ data_NNS
          files_NNS )_) ._. This_DT analysis_NN highlighted_VBN known_VBN markers_NNS of_IN
          toxicity_NN as_RB well_RB as_IN many_JJ genes_NNS identified_VBN in_IN previous_JJ CCl_NNP
          
          4_LS studies_NNS ,_, most_RBS notably_RB that_IN for_IN LRF-_NNP 1_CD
          (_( M_NNP 63282_CD )_) ,_, a_DT known_VBN regulator_NN of_IN proliferation_NN during_IN liver_NN
          regeneration_NN following_VBG injury_NN ,_, as_RB well_RB as_IN the_DT genes_NNS for_IN
          vitronectin_NN (_( U_NNP 44845_CD )_) and_CC α_NN glutathione-_NN 
          S_NNP -_: transferase_NN Mu_NNP isoform_NN (_( U_NNP 86635_CD )_)
          [_NN 7_CD 16_CD 17_CD ]_NN ._.
          A_DT number_NN of_IN genes_NNS correlating_VBG with_IN tissue_NN features_NNS
          were_VBD distinct_JJ from_IN those_DT found_VBN by_IN a_DT twofold_NN ratio_NN
          analysis_NN [_NN 7_CD ]_NN ._. Assessment_NNP of_IN these_DT genes_NNS revealed_VBD an_DT
          association_NN with_IN the_DT known_VBN or_CC suspected_VBN genes_NNS involved_VBN in_IN
          the_DT biology_NN of_IN CCl_NNP 
          4_CD toxicity_NN ._. Correlations_NNP with_IN three_CD
          structural_JJ metrics_NNS were_VBD chosen_VBN for_IN examination_NN ,_, providing_VBG
          a_DT substantial_JJ number_NN of_IN genes_NNS :_: '_POS %_NN clear_JJ space_NN '_'' ,_, '_'' area_NN %_NN
          vacuoles_NNS '_POS and_CC '_POS vacuoles_NNS /_NN mm_NN 2_CD '_'' ._. The_DT tissue_NN metrics_NNS %_NN clear_JJ
          space_NN and_CC area_NN %_NN vacuoles_NNS were_VBD negatively_RB correlated_JJ with_IN
          at_IN least_JJS one_CD isoform_NN of_IN cytochrome_NN P_NN 450_CD (_( 3_CD A_DT 9_CD :_: U_NNP 46118_CD ,_,
          2_CD B_NNP 12_CD :_: X_NNP 63545_CD and_CC 2_CD B_NNP 3_CD :_: M_NNP 20406_CD )_) ,_, this_DT may_MD be_VB a_DT hallmark_NN of_IN
          recovery_NN ._. One_CD gene_NN common_JJ to_TO clear-space-related_JJ metrics_NNS
          (_( non-stained_JJ tissue_NN ,_, including_VBG vacuoles_NNS and_CC hydrophic_JJ
          degeneration_NN )_) was_VBD α-tubulin_JJ (_( V_NNP 01227_CD )_) ._. Tubulin_NNP levels_NNS do_VBP
          not_RB change_VB during_IN the_DT acute_JJ phase_NN of_IN CCl_NNP 
          4_CD poisoning_NN ,_, but_CC have_VBP been_VBN shown_VBN to_TO
          decrease_VB in_IN association_NN with_IN the_DT development_NN of_IN fatty_NN
          liver_NN tissue_NN as_IN a_DT result_NN of_IN chronic_JJ CCl_NNP 
          4_CD exposure_NN [_NN 18_CD 19_CD ]_NN ._. In_IN the_DT present_JJ
          study_NN ,_, tubulin_NN was_VBD positively_RB correlated_JJ with_IN the_DT three_CD
          components_NNS of_IN clear_JJ space_NN ,_, perhaps_RB indicating_VBG cellular_JJ
          reorganization_NN ._. Also_RB strongly_RB correlated_JJ with_IN all_DT three_CD
          clear-space_JJ metrics_NNS was_VBD 
          S_NNP -_: adenosylmethionine_NN synthetase_NN
          (_( X_NNP 60822_CD )_) (_( AdoMet_NNP synthetase_NN )_) ._. A_DT suppression_NN of_IN AdoMet_NNP
          synthetase_NN activity_NN has_VBZ been_VBN observed_VBN in_IN a_DT model_NN of_IN
          acetaminophen_NN toxicity_NN [_NN 20_CD ]_NN ._. The_DT negative_JJ correlation_NN
          of_IN AdoMet_NNP synthetase_NN mRNA_NN observed_VBD in_IN the_DT present_JJ study_NN
          suggests_VBZ that_IN CCl_NNP 
          4_CD toxicity_NN suppresses_NNS message_NN as_IN well_RB ,_,
          as_IN AdoMet_NNP synthetase_NN was_VBD most_RBS significantly_RB correlated_JJ
          with_IN %_NN clear_JJ space_NN ._.
          Expression_NNP of_IN distintegrin_NN metalloprotease_NN (_( Z_NNP 48444_CD )_)
          was_VBD positively_RB correlated_JJ with_IN the_DT two_CD vacuole-related_JJ
          metrics_NNS ._. This_DT is_VBZ an_DT ADAM_NNP 10_CD -_: homolog_NN known_VBN to_TO be_VB a_DT tumor_NN
          necrosis_NNS factor-α_JJ (_( TNFα_NNP )_) convertase_NN [_NN 21_CD ]_NN ,_, TNFα_NNP
          produced_VBN by_IN Kupffer_NNP cells_NNS in_IN the_DT liver_NN stimulates_NNS
          production_NN of_IN TNFα_NNP ,_, a_DT mitogen_NN for_IN hepatocytes_NNS helping_VBG to_TO
          generate_VB new_JJ cells_NNS needed_VBN to_TO rebuild_VB damaged_JJ areas_NNS of_IN the_DT
          liver_NN [_NN 22_CD ]_NN ._. Kupffer_NNP cells_NNS have_VBP a_DT significant_JJ role_NN as_IN
          mediators_NNS of_IN acute_JJ inflammation_NN after_IN CCl_NNP 
          4_CD treatment_NN ;_: however_RB ,_, they_PRP also_RB
          produce_VBP factors_NNS that_WDT can_MD cause_VB secondary_JJ injury_NN in_IN the_DT
          liver_NN through_IN fibrogenic_JJ responses_NNS ._. An_DT increase_NN in_IN a_DT TNFα_NNP
          convertase_NN would_MD ensure_VB that_IN any_DT residual_JJ cytokine_NN
          present_NN would_MD be_VB in_IN the_DT active_JJ stimulatory_NN form_NN ._. TNFα_NNP and_CC
          its_PRP$ receptor_NN ,_, along_IN with_IN interleukin-_NN 6_CD (_( IL-_NNP 6_CD )_) and_CC its_PRP$
          receptor_NN ,_, were_VBD both_DT upregulated_JJ in_IN the_DT present_JJ study_NN ,_, but_CC
          neither_DT was_VBD correlated_JJ with_IN a_DT tissue_NN metric_JJ below_IN the_DT
          0_CD ._. 01_CD 
          p_NN -_: value_NN threshold_NN ._.
          Different_JJ spectra_NN of_IN cytokines_NNS are_VBP associated_VBN with_IN
          toxicity_NN or_CC inflammation_NN compared_VBN to_TO tissue_NN repair_NN ._. In_IN
          the_DT present_JJ study_NN ,_, genes_NNS encoding_VBG many_JJ different_JJ
          cytokines_NNS were_VBD affected_VBN ;_: however_RB ,_, not_RB all_DT were_VBD
          significantly_RB correlated_JJ with_IN the_DT tissue_NN metrics_NNS examined_VBD
          in_IN this_DT analysis_NN ._. A_DT striking_JJ exception_NN was_VBD the_DT family_NN of_IN
          vascular_NN endothelial_NN growth_NN factors_NNS (_( VEGF_NNP )_) ._. The_DT role_NN of_IN
          VEGF_NNP in_IN the_DT recovery_NN of_IN necrotic_JJ liver_NN following_VBG CCl_NNP 
          4_CD treatment_NN has_VBZ been_VBN well_RB established_VBN
          [_NN 23_CD 24_CD ]_NN ._. Here_RB ,_, several_JJ VEGF_NNP isoforms_NNS were_VBD found_VBN to_TO
          correlate_VBP with_IN clear-space-related_JJ metrics_NNS ._. Isoforms_NNP B_NNP
          and_CC D_NNP (_( AF_NNP 022952_CD and_CC AF_NNP 014827_CD )_) were_VBD positively_RB correlated_JJ
          with_IN %_NN clear_JJ space_NN itself_PRP ,_, whereas_IN isoform_NN C_NNP (_( AF_NNP 010302_CD )_)
          was_VBD negatively_RB correlated_JJ with_IN both_DT area_NN %_NN vacuoles_NNS and_CC
          vacuoles_NNS /_NN mm_NN 2_CD ._. VEGF_NNP Ch_NNP was_VBD reported_VBN to_TO be_VB involved_VBN in_IN
          cancer_NN metastasis_NNS and_CC tumor-cell_JJ invasion_NN [_NN 25_CD 26_CD ]_NN ,_,
          whereas_IN isoforms_NNS B_NNP and_CC D_NNP are_VBP believed_VBN to_TO have_VB roles_NNS in_IN
          proliferation_NN and_CC tissue_NN remodeling_VBG [_NN 27_CD 28_CD 29_CD 30_CD ]_NN ,_,
          highlighting_VBG the_DT diverse_JJ roles_NNS of_IN these_DT cytokines_NNS ._. VEGF_NNP
          mRNA_NN peaks_NNS at_IN 72_CD hours_NNS after_IN CCl_NNP 
          4_CD treatment_NN in_IN Kupffer_NNP cells_NNS ,_, whereas_IN
          it_PRP peaks_NNS at_IN 7_CD days_NNS in_IN hepatocytes_NNS ,_, well_RB after_IN necrosis_NNS
          has_VBZ resolved_VBN and_CC when_WRB vascular_NN and_CC sinusoidal_NN endothelial_NN
          cells_NNS are_VBP reappearing_VBG in_IN the_DT tissue_NN [_NN 23_CD 31_CD ]_NN ._.
          Correlation_NNP of_IN VEGF_NNP isoforms_NNS with_IN specific_JJ tissue_NN metrics_NNS
          suggests_VBZ they_PRP have_VBP different_JJ roles_NNS in_IN the_DT regeneration_NN
          and_CC revascularization_NN of_IN severely_RB damaged_JJ areas_NNS of_IN the_DT
          treated_VBN livers_NNS ._.
          Both_DT the_DT heat-stable_JJ enterotoxin_NN receptor_NN (_( M_NNP 55636_CD )_) and_CC
          contrapsin-like_JJ protease_NN inhibitor_NN CPi-_NNP 26_CD (_( D_NNP 00753_CD )_)
          correlated_JJ with_IN %_NN clear_JJ space_NN and_CC area_NN %_NN vacuoles_NNS ._. The_DT
          enterotoxin_NN receptor_NN ,_, which_WDT is_VBZ a_DT marker_NN for_IN regeneration_NN
          in_IN both_DT partial_JJ hepatectomy_NN and_CC CCl_NNP 
          4_CD toxicity_NN [_NN 32_CD ]_NN ,_, was_VBD positively_RB
          correlated_JJ with_IN these_DT tissue_NN metrics_NNS ,_, whereas_IN CP_NNP 1_CD -_: 26_CD was_VBD
          negatively_RB correlated_JJ ._. SPI-_NNP 3_CD has_VBZ been_VBN shown_VBN to_TO be_VB a_DT
          downstream_JJ target_NN of_IN both_DT the_DT inflammatory_JJ acute-phase_JJ
          regulators_NNS TNFα_NNP and_CC IL-_NNP 6_CD [_NN 33_CD ]_NN ._. Positive_JJ correlation_NN
          with_IN an_DT intermediate_JJ conductance_NN calcium-activated_JJ
          potassium_NN channel_NN SMIK_NNP (_( AF_NNP 190458_CD )_) was_VBD common_JJ to_TO the_DT
          metrics_NNS related_VBN to_TO vacuole_NN density_NN ,_, area_NN %_NN vacuoles_NNS and_CC
          vacuoles_NNS /_NN mm_NN 2_CD ._. CCl_NNP 
          4_CD treatment_NN perturbs_NNS the_DT balance_NN of_IN
          many_JJ serum_NN electrolytes_NNS [_NN 34_CD ]_NN ,_, and_CC an_DT increase_NN in_IN the_DT
          SMIK_NNP channel_NN might_MD help_VB re-establish_VB normal_JJ potassium_NN
          homeostasis_NNS as_IN the_DT liver_NN recovers_VBZ from_IN the_DT toxic_JJ
          stress_NN ._.
          Correlations_NNP between_IN genes_NNS and_CC tissue_NN metrics_NNS may_MD
          reveal_VB interesting_JJ differences_NNS similar_JJ to_TO
          histomorphometric_JJ findings_NNS ._. For_IN example_NN ,_, the_DT vacuolar_NN
          metrics_NNS (_( area_NN %_NN vacuoles_NNS and_CC vacuoles_NNS /_NN mm_NN 2_LS )_) have_VBP genes_NNS
          uniquely_RB correlated_JJ with_IN each_DT ,_, demonstrating_VBG a_DT potential_JJ
          genetic_JJ basis_NN for_IN the_DT difference_NN between_IN the_DT number_NN and_CC
          size_NN of_IN vacuoles_NNS and_CC their_PRP$ density_NN ,_, or_CC packing_VBG ._. Vacuole_NNP
          density_NN was_VBD linked_VBN to_TO the_DT expression_NN of_IN wee_NN 1_CD tyrosine_NN
          kinase_NN (_( D_NNP 31838_CD )_) and_CC a_DT nuclear_JJ co-repressor_JJ (_( AF_NNP 059311_CD )_) as_RB
          well_RB as_IN IL-_NNP 5_CD and_CC -_: 12_CD (_( AJ_NNP 011299_CD and_CC AF_NNP 083329_CD )_) ,_, all_DT
          involved_VBN in_IN cell-cycle_JJ regulation_NN and_CC signaling_VBG ._. In_IN
          contrast_NN ,_, area_NN %_NN vacuoles_NNS was_VBD linked_VBN to_TO expression_NN of_IN
          interferon_NN regulatory_JJ factor_NN 1_CD (_( IRF-_NNP 1_CD ;_: M_NNP 34253_CD )_) ._. IRF-_NNP 1_CD has_VBZ
          been_VBN reported_VBN to_TO be_VB upregulated_JJ by_IN TNFα_NNP during_IN sepsis_NN [_NN
          35_CD ]_NN ._. The_DT correlation_NN between_IN this_DT cytokine_NN and_CC area_NN %_NN
          vacuoles_NNS but_CC not_RB with_IN vacuoles_NNS /_NN mm_NN 2_CD shows_VBZ the_DT dynamic_JJ
          balance_NN between_IN the_DT primary_JJ response_NN to_TO injury_NN and_CC tissue_NN
          proliferation_NN and_CC repair_NN ._. This_DT illustrates_VBZ how_WRB genes_NNS
          associated_VBN with_IN each_DT metric_NN could_MD help_VB define_VB molecular_JJ
          factors_NNS behind_IN complex_JJ cellular_JJ mechanisms_NNS ._.
          In_IN this_DT study_NN ,_, the_DT toxic_JJ injury_NN visible_JJ on_IN day_NN 4_CD was_VBD
          subsequently_RB reversed_VBN by_IN days_NNS 7_CD and_CC 14_CD ,_, with_IN decreasing_VBG
          impairment_NN indicated_VBN by_IN the_DT levels_NNS of_IN expression_NN of_IN
          metabolic_JJ genes_NNS ._. By_IN day_NN 14_CD ,_, there_EX was_VBD a_DT decrease_NN in_IN %_NN
          clear_JJ space_NN in_IN livers_NNS from_IN treated_VBN animals_NNS whereas_IN the_DT
          other_JJ metrics_NNS -_: area_NN %_NN vacuoles_NNS and_CC vacuoles_NNS /_NN mm_NN 2_CD -_:
          remained_VBD consistent_JJ over_IN time_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT
          findings_NNS hint_VBP at_IN the_DT important_JJ role_NN of_IN genes_NNS correlated_JJ
          with_IN %_NN clear_JJ space_NN in_IN the_DT balance_NN between_IN toxicity_NN ,_,
          repair_NN and_CC proliferation_NN occurring_VBG in_IN treated_VBN livers_NNS ._.
        
        
          PCA_NNP and_CC classification_NN
          PCA_NNP was_VBD used_VBN to_TO reduce_VB the_DT complexity_NN in_IN the_DT gene_NN ,_,
          tissue_NN and_CC combined_VBN profiles_NNS of_IN each_DT rat_NN liver_NN ._. From_IN
          these_DT analyses_NNS ,_, we_PRP determined_VBD the_DT principal_JJ component_NN
          that_WDT identified_VBD the_DT day-_NN 4_CD -_: treated_VBN animals_NNS ._. The_DT second_JJ
          principal_JJ component_NN of_IN the_DT gene-expression_JJ data_NN separated_JJ
          the_DT day-_NN 4_CD -_: treated_VBN animals_NNS from_IN all_DT others_NNS ,_, including_VBG the_DT
          remaining_VBG CCl_NNP 
          4_CD -_: treated_VBN days_NNS 7_CD and_CC 14_CD (_( Figure_NN 3_CD a_DT )_) ._.
          The_DT first_JJ principal_JJ component_NN separates_NNS the_DT two_CD groups_NNS
          for_IN the_DT tissue-only_JJ data_NN (_( Figure_NN 3_CD b_SYM )_) ,_, and_CC both_DT the_DT first_JJ
          and_CC second_JJ principal_JJ components_NNS track_VBP the_DT differences_NNS
          between_IN the_DT two_CD groups_NNS in_IN the_DT combined_VBN datasets_NNS (_( Figure_NN
          3_CD c_SYM )_) ._.
          Using_VBG the_DT first_JJ two_CD principal_JJ components_NNS ,_, we_PRP
          classified_VBD the_DT animals_NNS in_IN treated_VBN day-_NN 4_CD versus_CC control_NN
          and_CC other_JJ groups_NNS using_VBG a_DT quadratic_JJ regression_NN classifier_NN
          for_IN all_DT three_CD datasets_NNS ._. A_DT cross-validation_JJ estimate_NN of_IN
          the_DT probability_NN of_IN successful_JJ classification_NN of_IN the_DT
          animals_NNS was_VBD used_VBN to_TO determine_VB the_DT diagnostic_JJ strength_NN of_IN
          each_DT type_NN of_IN dataset_NN ._. Each_DT step_NN of_IN the_DT cross-validation_JJ
          calculated_VBD the_DT appropriate_JJ principal_JJ components_NNS for_IN all_DT
          but_CC one_CD animal_NN to_TO determine_VB the_DT parameters_NNS of_IN the_DT
          quadratic_JJ regression_NN classifier_NN ,_, and_CC then_RB the_DT remaining_VBG
          animal_NN was_VBD classified_VBN ._. This_DT was_VBD repeated_VBN so_IN that_IN every_DT
          observed_VBN animal_NN was_VBD left_VBN out_IN and_CC classified_VBN ._. The_DT
          resulting_VBG schema_NN can_MD identify_VB which_WDT animals_NNS were_VBD
          correctly_RB classified_VBN or_CC misclassified_VBN ._. With_IN this_DT method_NN
          we_PRP were_VBD able_JJ to_TO estimate_VB the_DT accuracy_NN of_IN developing_VBG a_DT
          well-defined_JJ classification_NN method_NN ._. In_IN practice_NN ,_, the_DT
          discrimination_NN rule_NN would_MD be_VB created_VBN on_IN a_DT training_NN set_NN of_IN
          data_NNS and_CC applied_VBN to_TO an_DT unknown_JJ set_VBN ;_: therefore_RB a_DT high_JJ
          cross-validation_JJ probability_NN of_IN successful_JJ classification_NN
          for_IN developing_VBG a_DT well-defined_JJ discrimination_NN rule_NN is_VBZ
          important_JJ ._.
          This_DT analysis_NN was_VBD carried_VBN out_IN on_IN gene_NN expression_NN and_CC
          tissue_NN features_NNS separately_RB and_CC on_IN the_DT combined_VBN dataset_NN ._.
          Using_VBG gene-expression_JJ data_NNS only_RB ,_, the_DT correct_JJ
          classification_NN probability_NN was_VBD 96_CD ._. 43_CD %_NN ._. Using_VBG the_DT
          tissue-feature_JJ data_NN ,_, correct_JJ classification_NN was_VBD 92_CD ._. 86_CD %_NN ._.
          Finally_RB ,_, using_VBG the_DT combined_VBN data_NN ,_, accuracy_NN for_IN correct_JJ
          classification_NN was_VBD 96_CD ._. 43_CD %_NN ._. The_DT strong_JJ correlations_NNS
          between_IN tissue_NN features_NNS and_CC genes_NNS allowed_VBN for_IN the_DT
          prediction_NN of_IN the_DT tissue_NN metrics_NNS from_IN the_DT gene_NN dataset_NN
          but_CC not_RB the_DT genes_NNS from_IN the_DT tissue-feature_JJ data_NN ;_: note_NN that_IN
          this_DT is_VBZ due_JJ to_TO the_DT fact_NN that_IN it_PRP is_VBZ easier_JJR to_TO predict_VB 11_CD
          tissue_NN metrics_NNS from_IN 1_CD ,_, 040_CD genes_NNS than_IN vice_NN versa_RB ._.
          Therefore_RB ,_, inclusion_NN of_IN tissue_NN data_NNS in_IN the_DT combined_VBN set_VBN
          did_VBD not_RB necessarily_RB improve_VB the_DT classification_NN using_VBG just_RB
          the_DT gene-expression_JJ data_NN ._. Comparing_VBG the_DT misclassified_VBN
          animals_NNS from_IN both_DT sets_NNS ,_, however_RB ,_, revealed_VBD differences_NNS for_IN
          genes_NNS compared_VBN to_TO tissue_NN features_NNS ._. These_DT differences_NNS can_MD
          be_VB used_VBN for_IN diagnostic_JJ purposes_NNS by_IN comparing_VBG the_DT
          classification_NN of_IN outlier_NN animals_NNS ,_, and_CC to_TO examine_VB more_RBR
          closely_RB the_DT underlying_VBG components_NNS in_IN both_DT the_DT molecular_JJ
          and_CC phenotypic_JJ response_NN to_TO a_DT toxin_NN ._.
          The_DT introduction_NN of_IN robust_JJ machine-vision_JJ techniques_NNS
          that_WDT can_MD consistently_RB discern_VB the_DT histomorphology_NN of_IN
          tissues_NNS in_IN a_DT comprehensive_JJ fashion_NN will_MD support_VB
          pathologic_JJ assessments_NNS allowing_VBG a_DT more_RBR quantitative_JJ
          evaluation_NN of_IN phenotypic_JJ responses_NNS to_TO compounds_NNS ._.
          Investigations_NNP can_MD be_VB carried_VBN out_IN in_IN an_DT automated_VBN ,_,
          unsupervised_JJ fashion_NN necessary_JJ for_IN high-throughput_JJ
          analyses_NNS ._. The_DT EMeRGE_NNP method_NN demonstrated_VBD correlations_NNS
          between_IN specific_JJ genes_NNS and_CC tissue_NN structures_NNS that_WDT can_MD
          augment_VB interpretation_NN of_IN biological_JJ observations_NNS and_CC
          diagnosis_NN ._. These_DT correlations_NNS illustrate_VBP a_DT new_JJ paradigm_NN
          that_IN phenotypically_RB anchors_NNS changes_NNS in_IN gene_NN expression_NN to_TO
          structural_JJ features_NNS in_IN tissue_NN ._. Improved_JJ outlier_NN detection_NN
          may_MD be_VB attained_VBN with_IN a_DT combination_NN of_IN gene-expression_JJ and_CC
          tissue_NN phenotypic_JJ data_NNS ._. The_DT improved_VBN objectivity_NN and_CC
          reproducibility_NN of_IN phenotypic_JJ assessments_NNS correlated_JJ with_IN
          gene-expression_JJ data_NNS is_VBZ a_DT step_NN forward_RB in_IN tissue_NN analysis_NN
          that_WDT will_MD impact_VB on_IN the_DT definition_NN of_IN therapeutic_JJ margins_NNS
          and_CC help_VB refine_VB dose_NN levels_NNS ,_, as_RB well_RB as_IN improve_VB
          identification_NN of_IN atypical_JJ responses_NNS ._. Other_JJ covariants_NNS
          such_JJ as_IN clinical_JJ chemistry_NN parameters_NNS can_MD be_VB added_VBN to_TO
          this_DT analysis_NN for_IN an_DT even_RB deeper_JJR view_NN [_NN 1_CD ]_NN ._. Combined_VBN
          analyses_NNS ,_, such_JJ as_IN EMeRGE_NNP ,_, can_MD be_VB applied_VBN to_TO any_DT
          experimental_JJ or_CC pathologic_JJ conditions_NNS where_WRB gene_NN
          expression_NN and_CC tissue_NN histology_NN are_VBP integral_JJ to_TO the_DT
          interpretation_NN of_IN toxic_JJ or_CC pharmacologic_JJ events_NNS as_RB well_RB
          as_IN to_TO the_DT pathophysiology_NN of_IN disease_NN ._.
        
      
      
        Materials_NNS and_CC methods_NNS
        
          Experimental_NNP protocol_NN
          Six_CD groups_NNS of_IN five_CD male_JJ ,_, age-_NN and_CC weight-matched_JJ ,_,
          Sprague-_NNP Dawley_NNP rats_NNS were_VBD separated_JJ into_IN three_CD groups_NNS of_IN
          vehicle_NN controls_NNS and_CC three_CD groups_NNS of_IN CCl_NNP 
          4_CD -_: treated_VBN animals_NNS ._. Each_DT rat_NN was_VBD dosed_JJ
          once_RB daily_JJ on_IN days_NNS 1_CD ,_, 2_CD and_CC 3_CD by_IN intraperitoneal_NN
          injections_NNS of_IN either_DT pure_JJ corn-oil_JJ vehicle_NN or_CC CCl_NNP 
          4_CD dissolved_VBN in_IN corn_NN oil_NN (_( approximately_RB
          15_CD %_NN v_NN /_NN v_NN )_) at_IN a_DT dose_NN of_IN 1_CD ,_, 000_CD mg_NN /_NN kg_NN /_NN day_NN [_NN 1_CD ]_NN ._. Animals_NNS
          were_VBD euthanized_JJ by_IN CO_NNP 
          2_CD asphyxiation_NN and_CC exsanguination_NN
          following_VBG a_DT 24_CD h_NN fast_RB on_IN either_DT day_NN 4_CD ,_, 7_CD ,_, or_CC 14_CD ,_, and_CC
          tissues_NNS were_VBD harvested_VBN for_IN analysis_NN ._. The_DT central_JJ lobe_NN of_IN
          each_DT liver_NN was_VBD harvested_VBN at_IN necropsy_NN ,_, and_CC approximately_RB 1_CD
          g_SYM was_VBD flash_VBP frozen_VBN in_IN liquid_JJ nitrogen_NN ._. RNA_NNP was_VBD extracted_VBN
          using_VBG TRIzol_NNP reagent_NN according_VBG to_TO the_DT protocol_NN from_IN
          Gibco-_NNP BRL_NNP ._. The_DT remaining_VBG liver_NN fraction_NN was_VBD fixed_VBN in_IN 10_CD %_NN
          formalin_NN ._.
        
        
          Sample_NNP preparation_NN ,_, hybridization_NN and_CC
          scanning_VBG
          Total_NNP RNA_NNP was_VBD quantified_VBN and_CC assessed_VBN for_IN quality_NN on_IN a_DT
          Bioanalyzer_NNP RNA_NNP chip_NN (_( Agilent_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) ._. Each_DT chip_NN
          contains_VBZ a_DT set_NN of_IN interconnected_VBN gel-filled_JJ channels_NNS that_WDT
          enables_VBZ molecular_JJ sieving_VBG of_IN nucleic_JJ acids_NNS ._.
          Pin-electrodes_NNP in_IN the_DT chip_NN create_VB electrokinetic_JJ forces_NNS
          that_WDT drive_NN molecules_NNS through_IN these_DT microchannels_NNS and_CC
          carry_VB out_IN electrophoretic_JJ separations_NNS ._. Ribosomal_NNP RNA_NNP
          peaks_NNS are_VBP measured_VBN by_IN fluorescence_NN signal_NN and_CC displayed_VBN
          in_IN an_DT electropherogram_NN ._. A_DT successful_JJ total_JJ RNA_NNP sample_NN
          featured_VBD two_CD distinct_JJ ribosomal_JJ peaks_NNS (_( 18_CD S_NNP and_CC 28_CD S_NNP rRNA_NN )_) ._.
          First-strand_NNP cDNA_NN was_VBD prepared_VBN ,_, labeled_VBN and_CC processed_VBN as_IN
          described_VBN in_IN the_DT Motorola_NNP CodeLink_NNP system_NN protocols_NNS ._.
          Processed_NNP arrays_NNS were_VBD scanned_JJ using_VBG an_DT GenePix_NNP Scanner_NNP
          (_( Axon_NNP Instruments_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP )_) ;_: array_NN images_NNS were_VBD
          acquired_VBN using_VBG the_DT Motorola_NNP CodeLink_NNP ™_NN Analysis_NNP Software_NNP
          (_( Amersham_NNP Biosciences_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ._.
        
        
          ADME_NNP rat_NN bioarray_NN system_NN and_CC data_NNS
          preparation_NN
          The_DT Motorola_NNP CodeLink_NNP ™_NN ADME_NNP Rat_NNP Bioarray_NNP consists_VBZ of_IN
          1_CD ,_, 137_CD oligonucleotide_NN probes_NNS corresponding_JJ to_TO 1_CD ,_, 040_CD
          unique_JJ clusters_NNS and_CC 97_CD control_NN probes_NNS ,_, selected_VBN from_IN
          GenBank_NNP Rodent_NNP and_CC RefSeq_NNP build_VBP number_NN 122_CD ._. Each_DT 30_CD
          base-pair_JJ (_( bp_NN )_) probe_NN is_VBZ was_VBD spotted_VBN in_IN triplicate_NN ._. All_DT
          samples_NNS were_VBD hybridized_JJ to_TO two_CD microarrays_NNS resulting_VBG in_IN
          six_CD data_NNS points_NNS per_IN probe_NN ._.
          The_DT Motorola_NNP CodeLink_NNP ™_NN Analysis_NNP Software_NNP gives_VBZ an_DT
          integrated_VBN optical_JJ density_NN (_( IOD_NNP )_) value_NN for_IN every_DT spot_NN ;_: a_DT
          unique_JJ background_NN value_NN for_IN that_DT spot_NN is_VBZ subtracted_VBN ,_,
          resulting_VBG in_IN '_POS raw_JJ '_POS data_NNS points_NNS ._.
        
        
          Histomorphometric_NNP profiling_VBG
          The_DT remaining_VBG portion_NN of_IN the_DT central_JJ lobe_NN was_VBD fixed_VBN in_IN
          formalin_NN ,_, embedded_VBN in_IN paraffin_NN ,_, sectioned_JJ (_( 5_CD μm_NN )_) and_CC
          stained_JJ with_IN hematoxylin_NN and_CC eosin_NN (_( H_NNP &_CC E_NNP )_) ._. An_DT
          automated_VBN analytical_JJ microscope_NN system_NN (_( ARTIS_NNP ™_NN ,_,
          TissueInformatics_NNP )_) was_VBD used_VBN to_TO scan_VB the_DT entire_JJ slide_NN at_IN a_DT
          low_JJ resolution_NN to_TO identify_VB tissue_NN locations_NNS ._. The_DT smallest_JJS
          possible_JJ rectangular_JJ region_NN fully_RB encompassing_VBG each_DT
          tissue_NN section_NN was_VBD captured_VBN at_IN a_DT high_JJ resolution_NN at_IN 0_CD ._. 64_CD
          μm_NN /_NN pixel_NN on_IN a_DT tile-by-tile_JJ basis_NN ,_, generating_NN 100_CD -_: 400_CD
          individual_JJ digital_JJ image_NN tiles_NNS per_IN slide_NN ._. Each_DT individual_JJ
          image_NN tile_NN was_VBD automatically_RB focused_VBN ,_, captured_VBN ,_,
          digitized_JJ ,_, corrected_VBN for_IN shading_VBG and_CC analyzed_VBD ._.
          The_DT methodology_NN was_VBD developed_VBN for_IN image_NN segmentation_NN
          and_CC trained_VBN for_IN object_VBP classification_NN using_VBG a_DT
          representative_NN set_NN of_IN images_NNS from_IN controls_NNS and_CC treated_VBN
          rat_NN liver_NN specimen_NN from_IN various_JJ studies_NNS ,_, before_IN the_DT
          system_NN was_VBD applied_VBN the_DT specimen_NN of_IN this_DT study_NN ._. As_IN a_DT
          precursor_NN to_TO any_DT segmentation_NN operation_NN the_DT input_NN 24_CD -_: bit_NN
          RGB_NNP images_NNS of_IN H_NNP &_CC E-_NNP prepared_VBD tissue_NN were_VBD converted_VBN
          using_VBG a_DT stain_VB space_NN conversion_NN ,_, based_VBN on_IN PCA_NNP ._. This_DT
          technique_NN effectively_RB allowed_VBD each_DT pixel_NN in_IN the_DT image_NN to_TO
          be_VB mapped_VBN to_TO its_PRP$ respective_JJ stain-absorption_JJ value_NN to_TO
          give_VB an_DT invariant_NN representation_NN of_IN the_DT histologic_JJ
          properties_NNS of_IN the_DT image_NN ._. Once_RB the_DT stain_VB value_NN at_IN each_DT
          pixel_NN was_VBD determined_VBN ,_, a_DT generalized_JJ grouping_VBG was_VBD used_VBN to_TO
          account_VB for_IN regional_JJ features_NNS ,_, such_JJ as_IN nuclei_NN ,_, which_WDT bind_NN
          the_DT stain_VB ._. Similar_JJ high-level_JJ segmentation_NN accounted_VBD for_IN
          other_JJ object_VBP types_NNS within_IN the_DT tissue_NN -_: namely_RB clear_JJ
          space_NN ,_, vacuoles_NNS ,_, sinusoids_NNS and_CC cytoplasmic_JJ material_NN -_:
          that_IN generally_RB tend_VBP to_TO absorb_VB (_( or_CC not_RB absorb_VB )_) one_CD type_NN of_IN
          stain_VB ._.
          Hepatic_NNP cells_NNS comprise_VBP approximately_RB 80_CD %_NN of_IN the_DT volume_NN
          of_IN the_DT liver_NN and_CC 60_CD %_NN of_IN the_DT cell_NN count_NN ._. They_PRP vary_VBP in_IN
          shape_NN and_CC texture_NN (_( both_DT in_IN nuclei_NN and_CC cytoplasm_NN )_) from_IN one_CD
          liver_NN zone_NN to_TO another_DT ._. Conditions_NNP such_JJ as_IN hyperplasia_NN and_CC
          hypertrophy_NN and_CC other_JJ metabolic_JJ conditions_NNS may_MD affect_VB the_DT
          appearance_NN of_IN nuclei_NN and_CC the_DT surrounding_VBG cytoplasm_NN as_IN a_DT
          result_NN of_IN tissue_NN injury_NN ._.
          Definition_NNP of_IN the_DT invariant_NN characteristics_NNS of_IN hepatic_JJ
          nuclei_NN made_VBD a_DT robust_JJ segmentation_NN possible_JJ and_CC included_VBD
          the_DT following_VBG features_NNS ._. Hepatic_NNP nuclei_NN have_VBP a_DT dark-blue_JJ
          appearance_NN as_IN a_DT result_NN of_IN the_DT absorption_NN of_IN hematoxylin_NN ._.
          They_PRP may_MD contain_VB nucleoli_NN ,_, or_CC chromatin_NN figures_NNS internal_JJ
          to_TO the_DT nuclei_NN ._. This_DT will_MD be_VB exhibited_VBN as_IN a_DT conic_JJ boundary_NN
          with_IN a_DT clear_JJ internal_JJ structure_NN highlighted_VBN by_IN dark_JJ
          annotations_NNS ._. They_PRP are_VBP generally_RB round_NN or_CC polyhedral_NN in_IN
          shape_NN ._. They_PRP will_MD have_VB a_DT general_JJ size_NN boundary_NN (_( correlated_JJ
          to_TO the_DT image_NN capture_NN magnification_NN )_) ;_: variance_NN will_MD exist_VB
          between_IN each_DT layer_NN of_IN the_DT liver_NN ._. They_PRP are_VBP highlighted_VBN
          from_IN the_DT background_NN tissue_NN by_IN the_DT differential_NN stain_VB
          properties_NNS of_IN hematoxylin_NN ,_, offsetting_VBG nuclear_JJ material_NN
          from_IN the_DT surrounding_VBG cytoplasm_NN ._.
          For_IN classification_NN ,_, a_DT probability_NN model_NN was_VBD used_VBN where_WRB
          each_DT pixel_NN expressing_VBG hematoxylin_NN stain_VB contains_VBZ a_DT vector_NN
          of_IN attributes_NNS that_IN denotes_NNS the_DT probability_NN of_IN the_DT pixel_NN
          belonging_VBG to_TO a_DT nucleus_NN object_NN ._. Candidate_NNP objects_NNS can_MD be_VB
          readily_RB found_VBN by_IN locating_VBG local_JJ maxima_NN in_IN the_DT
          hematoxylin-stained_JJ image_NN (_( expressed_VBD as_IN a_DT ratio_NN of_IN
          hematoxylin_NN and_CC eosin_NN with_IN a_DT spatial_NN filter_NN applied_VBN to_TO
          reduce_VB noise_NN )_) ._. The_DT vector_NN is_VBZ composed_VBN of_IN elements_NNS such_JJ as_IN
          stain-value_JJ deviation_NN ,_, size_NN ,_, shape_NN ,_, and_CC texture_NN
          measurements_NNS of_IN internally_RB visible_JJ chromatin_NN and_CC /_NN or_CC
          nucleoli_NN ._. Proper_JJ values_NNS for_IN these_DT vectors_NNS were_VBD learned_VBN by_IN
          a_DT simple_JJ neural_NN network_NN model_NN and_CC used_VBN to_TO classify_VB
          objects_NNS into_IN appropriate_JJ categories_NNS (_( for_IN example_NN ,_, hepatic_JJ
          nucleus_NN or_CC non-hepatic_JJ nucleus_NN )_) ._. At_IN times_NNS ,_, representative_NN
          elements_NNS of_IN this_DT vector_NN were_VBD misleading_JJ ,_, because_IN of_IN
          artifacts_NNS in_IN histology_NN preparation_NN and_CC sectioning_VBG ._. These_DT
          errors_NNS were_VBD resolved_VBN by_IN applying_VBG pre-filtering_JJ to_TO each_DT
          vector_NN element_NN before_IN comparison_NN with_IN the_DT neural_NN network_NN ._.
          For_IN example_NN ,_, nuclei_NN with_IN a_NNP '_POS half-moon_JJ '_POS silhouette_NN caused_VBD
          by_IN the_DT sectioning_VBG process_NN will_MD be_VB misleading_JJ ._. In_IN this_DT
          case_NN ,_, fitting_JJ a_DT polygon_NN to_TO the_DT boundary_NN and_CC extracting_VBG
          hull-properties_JJ for_IN the_DT classification_NN can_MD make_VB a_DT solid_JJ
          differentiation_NN ._.
          Once_RB the_DT non-hepatic_JJ nuclei_NN objects_NNS were_VBD separated_JJ
          from_IN the_DT surrounding_VBG tissue_NN ,_, they_PRP were_VBD differentiated_JJ
          further_RB by_IN applying_VBG spatial_NN characteristics_NNS derived_VBN from_IN
          the_DT architecture_NN of_IN the_DT liver_NN ._. Both_DT size_NN and_CC eccentricity_NN
          acted_VBD as_IN a_DT differentiator_NN ,_, as_RB well_RB as_IN encapsulation_NN by_IN or_CC
          nearness_NNS to_TO sinusoids_NNS (_( clear_JJ space_NN )_) ._. These_DT rules_NNS were_VBD
          fairly_RB invariant_NN and_CC had_VBD proved_VBN robust_JJ in_IN validation_NN
          protocols_NNS graded_JJ by_IN pathologists_NNS on_IN how_WRB well_RB a_DT feature_NN
          was_VBD discriminated_JJ ._. The_DT cellular_JJ architecture_NN of_IN the_DT liver_NN
          allowed_VBN for_IN robust_JJ training_NN data_NNS to_TO be_VB automatically_RB
          characterized_VBN by_IN the_DT system_NN ._. Objects_NNP were_VBD assigned_VBN
          '_POS rankings_NNS '_POS of_IN their_PRP$ probability_NN of_IN belonging_VBG to_TO a_DT given_VBN
          class_NN plotted_VBD against_IN spatial_NN relationships_NNS ,_, allowing_VBG for_IN
          quick_JJ identification_NN and_CC correction_NN of_IN errors_NNS ;_: for_IN
          example_NN ,_, an_DT object_VBP classified_VBN as_IN a_DT Kupffer_NNP nucleus_NN (_( other_JJ
          nucleus_NN )_) should_MD not_RB exist_VB outside_IN of_IN a_DT certain_JJ proximity_NN
          to_TO a_DT sinusoid_NN ._.
          Other_JJ elements_NNS in_IN the_DT liver_NN could_MD be_VB derived_VBN with_IN
          similar_JJ morphometric_JJ comparisons_NNS utilizing_VBG simple_JJ
          pattern-recognition_JJ classifiers_NNS for_IN optimal_NN performance_NN ._.
          Micro-_NNP and_CC macrovesicular_NN change_NN were_VBD detected_VBN by_IN
          thresholding_VBG the_DT resultant_JJ clear-space_JJ image_NN (_( derived_VBN by_IN
          calculating_VBG tissue_NN pixels_NNS that_WDT do_VBP not_RB contain_VB stain_VB )_) in_IN
          the_DT saturation_NN plane_NN and_CC locating_VBG '_POS round_NN '_'' objects_NNS ._.
          Similarly_RB ,_, performance_NN was_VBD improved_VBN by_IN localizing_VBG red_JJ
          blood_NN cells_NNS ,_, identified_VBN by_IN strong_JJ eosin_NN stain_VB band_NN
          expression_NN ,_, to_TO oblong_NN white_JJ objects_NNS ,_, as_IN they_PRP are_VBP
          typically_RB found_VBN in_IN intrasinusoidal_NN space_NN ._.
          All_DT nuclei_NN were_VBD then_RB masked_VBN out_IN of_IN the_DT original_JJ tissue_NN
          mask_NN ,_, and_CC clear-space_JJ areas_NNS were_VBD identified_VBN by_IN performing_VBG
          an_DT automatic_JJ threshold_NN in_IN the_DT intensity_NN band_NN of_IN the_DT
          masked_VBN image_NN ._. Binary_NNP clear_JJ space_NN areas_NNS were_VBD classified_VBN as_IN
          vacuoles_NNS or_CC as_IN general_JJ white_JJ space_NN objects_NNS based_VBN on_IN
          circularity_NN and_CC size_NN ._. A_DT texture_NN measure_NN was_VBD developed_VBN ,_,
          based_VBN on_IN a_DT gradient-filtered_JJ image_NN ,_, as_IN an_DT indicator_NN of_IN
          fine_NN spatial_NN changes_NNS in_IN the_DT cytoplasm_NN [_NN 36_CD ]_NN ._. The_DT
          cytoplasm_NN of_IN control_NN livers_NNS had_VBD a_DT smooth_JJ and_CC uniform_NN
          appearance_NN ,_, compared_VBN to_TO that_DT of_IN treated_VBN animals_NNS ,_, which_WDT
          exhibits_VBZ more_JJR roughness_NNS ,_, mainly_RB caused_VBN by_IN vacuoles_NNS ._.
          After_IN training_NN ,_, the_DT system_NN was_VBD applied_VBN to_TO the_DT specimen_NN
          of_IN this_DT study_NN and_CC all_DT analytical_JJ steps_NNS were_VBD executed_VBN
          fully_RB automatically_RB and_CC without_IN further_JJ user_NN interaction_NN ._.
          The_DT derived_VBN tissue_NN metrics_NNS included_VBD hepatocyte_NN and_CC other_JJ
          nuclei_NN ,_, sinusoids_NNS ,_, vacuoles_NNS including_VBG conglomerates_NNS of_IN
          microvesicular_NN change_NN ,_, counts_NNS of_IN each_DT feature_NN per_IN mm_NN 2_CD ,_, %_NN
          area_NN of_IN each_DT feature_NN respective_JJ to_TO the_DT total_JJ tissue_NN area_NN
          of_IN each_DT section_NN ,_, total_JJ %_NN clear_JJ space_NN (_( non-stained_JJ
          cellular_JJ and_CC tissue_NN elements_NNS )_) ,_, and_CC %_NN hematoxylin_NN stained_JJ
          objects_NNS (_( nuclei_NN )_) and_CC a_DT texture_NN feature_NN ._. A_DT reference_NN set_NN
          of_IN 24_CD images_NNS was_VBD selected_VBN for_IN validation_NN ._. Two_CD images_NNS from_IN
          two_CD animals_NNS from_IN all_DT groups_NNS ,_, control_NN and_CC treated_VBN ,_, were_VBD
          randomly_RB selected_VBN ._. The_DT system_NN used_VBN in_IN this_DT study_NN was_VBD
          validated_JJ for_IN the_DT detection_NN of_IN basic_JJ tissue_NN elements_NNS
          including_VBG hepatocyte_NN nuclei_NN ,_, other_JJ nuclei_NN ,_, vacuoles_NNS and_CC
          sinusoids_NNS ._. Two_CD pathologists_NNS independently_RB inspected_VBD the_DT
          classified_VBN objects_NNS indicated_VBN by_IN colored_VBN overlays_VBZ on_IN the_DT
          digital_JJ images_NNS ._. Typically_RB ,_, there_RB are_VBP about_IN 250_CD -_: 450_CD
          hepatocyte_NN nuclei_NN ,_, 20_CD -_: 130_CD non-hepatocyte_JJ nuclei_NN ,_, 50_CD -_: 300_CD
          vacuoles_NNS and_CC 70_CD -_: 200_CD sinusoids_NNS in_IN any_DT one_CD image_NN ._.
          False-positive_NNP '_POS hits_NNS '_POS and_CC missed_VBD false-negative_JJ
          identifications_NNS of_IN nuclei_NN were_VBD counted_VBN ._. Results_NNS for_IN
          hepatocytes_NNS nuclei_NN were_VBD less_JJR than_IN 3_CD %_NN false_JJ negative_JJ and_CC
          less_JJR than_IN 2_CD %_NN false_JJ positive_NN ;_: for_IN other_JJ nuclei_NN ,_, less_JJR than_IN
          7_CD %_NN false_JJ negative_JJ and_CC less_JJR than_IN 15_CD %_NN false_JJ positive_NN ._. The_DT
          percentage_NN of_IN correctly_RB detected_VBD vacuoles_NNS including_VBG
          conglomerates_NNS of_IN microvesicular_NN change_NN and_CC sinusoids_NNS were_VBD
          determined_VBN by_IN an_DT estimation_NN of_IN correct_JJ identification_NN ._.
          The_DT result_NN for_IN vacuoles_NNS and_CC conglomerates_NNS of_IN
          microvesicular_NN change_NN were_VBD in_IN the_DT range_NN of_IN less_JJR than_IN 40_CD %_NN
          false_JJ negative_JJ and_CC less_JJR than_IN 10_CD %_NN false_JJ positive_NN ._. Smaller_JJR
          vacuoles_NNS could_MD not_RB be_VB correctly_RB identified_VBN because_IN of_IN
          resolution_NN limits_NNS ,_, but_CC the_DT heterogeneity_NN in_IN the_DT cytoplasm_NN
          could_MD be_VB detected_VBN by_IN the_DT texture_NN analysis_NN ._. Estimate_NNP for_IN
          sinusoids_NNS was_VBD in_IN the_DT range_NN of_IN less_JJR than_IN 5_CD %_NN false_JJ negative_JJ
          and_CC less_JJR than_IN 20_CD %_NN false_JJ positive_NN ._.
          The_DT field-specific_JJ features_NNS clear_JJ space_NN ,_,
          hematoxylin-stained_JJ areas_NNS and_CC texture_NN have_VBP no_DT direct_JJ
          quantifiable_JJ visual_JJ correlation_NN ;_: this_DT also_RB applies_VBZ to_TO
          geometric_JJ and_CC density_NN features_NNS that_WDT are_VBP derived_VBN from_IN the_DT
          basic_JJ tissue_NN elements_NNS and_CC therefore_RB cannot_NN be_VB validated_JJ
          by_IN human_JJ observation_NN ._.
        
        
          Statistical_NNP data_NNS analysis_NN
          The_NNP '_POS raw_JJ '_POS microarray_NN data_NNS ,_, consisting_VBG of_IN six_CD readouts_NNS
          per_IN gene_NN ,_, were_VBD prepared_VBN for_IN analysis_NN by_IN removing_VBG outliers_NNS
          and_CC undergoing_VBG normalization_NN ._. Generally_RB ,_, outliers_NNS result_VBP
          in_IN expression_NN values_NNS that_WDT are_VBP much_RB larger_JJR than_IN expected_VBN ._.
          To_TO minimize_VB the_DT effects_NNS of_IN the_DT outliers_NNS ,_, an_DT outlier_NN
          detection_NN filter_NN was_VBD applied_VBN to_TO the_DT data_NNS ._. First_LS ,_, the_DT
          median_NN of_IN each_DT set_NN of_IN six_CD data_NNS points_NNS was_VBD calculated_VBN ,_,
          then_RB the_DT absolute_JJ value_NN of_IN the_DT difference_NN between_IN each_DT
          data_NNS point_VBP and_CC the_DT median_NN of_IN the_DT set_VBN to_TO which_WDT it_PRP belonged_VBD
          was_VBD calculated_VBN ._. The_DT median_JJ absolute_JJ deviation_NN was_VBD then_RB
          determined_VBN ._. A_DT modified_VBN z-score_JJ for_IN each_DT original_JJ
          gene-expression_JJ value_NN was_VBD derived_VBN as_IN the_DT absolute_JJ
          difference_NN between_IN the_DT original_JJ data_NN point_VBP and_CC the_DT median_NN
          of_IN the_DT set_VBN to_TO which_WDT it_PRP belonged_VBD ,_, multiplied_VBN by_IN 0_CD ._. 6745_CD and_CC
          divided_VBN by_IN the_DT median_JJ absolute_JJ difference_NN for_IN the_DT set_VBN [_NN
          37_CD ]_NN ._. Then_RB ,_, if_IN the_DT largest_JJS gene-expression_JJ value_NN in_IN a_DT
          given_VBN set_NN of_IN six_CD values_NNS had_VBD a_DT modified_VBN z-score_JJ larger_JJR
          than_IN 8_CD ._. 7_CD ,_, it_PRP was_VBD labeled_VBN an_DT outlier_NN and_CC removed_VBN from_IN the_DT
          raw_JJ dataset_NN ._. Only_RB 0_CD ._. 3_CD %_NN of_IN all_DT raw_JJ data_NN points_NNS were_VBD
          determined_VBN to_TO be_VB outliers_NNS using_VBG this_DT method_NN ._. After_IN
          outlier_NN removal_NN ,_, the_DT resulting_VBG datasets_NNS were_VBD normalized_JJ
          with_IN respect_NN to_TO the_DT median_JJ value_NN of_IN all_DT raw_JJ data_NN points_NNS
          on_IN a_DT given_VBN microarray_NN to_TO adjust_VB for_IN array-to-array_JJ
          variability_NN ._. The_DT medians_NNS of_IN the_DT remaining_VBG gene-expression_JJ
          values_NNS for_IN each_DT probe_NN on_IN the_DT microarray_NN were_VBD then_RB
          calculated_VBN and_CC used_VBN for_IN further_JJ analysis_NN ._. This_DT data_NNS
          preparation_NN resulted_VBD in_IN one_CD gene-expression_JJ value_NN per_IN
          gene_NN per_IN animal_NN and_CC is_VBZ referred_VBN to_TO as_IN the_DT '_POS normalized_JJ '_POS
          dataset_NN ._.
          Spearman_NNP 's_POS rank_NN order_NN correlation_NN is_VBZ a_DT rank-based_JJ
          adjustment_NN to_TO Pearson_NNP 's_POS correlation_NN ,_, which_WDT checks_VBZ for_IN
          strength_NN of_IN a_DT linear_JJ relationship_NN between_IN two_CD variables_NNS [_NN
          38_CD ]_NN ._. Spearman_NNP 's_POS rank_NN order_NN correlation_NN ranks_VBZ the_DT data_NNS
          in_IN each_DT variable_JJ and_CC then_RB calculates_VBZ Pearson_NNP 's_POS
          correlation_NN with_IN the_DT paired_VBN ranked_VBD data_NNS ,_, hence_RB checking_NN
          for_IN the_DT strength_NN of_IN a_DT monotone_NN relationship_NN ;_: 
          p_NN -_: values_NNS are_VBP based_VBN on_IN permutation_NN
          methods_NNS ._.
          PCA_NNP is_VBZ a_DT statistical_JJ technique_NN to_TO reduce_VB the_DT
          dimensionality_NN of_IN a_DT dataset_NN while_IN retaining_VBG as_IN much_JJ of_IN
          the_DT variability_NN as_IN possible_JJ [_NN 15_CD ]_NN ._. Each_DT principal_JJ
          component_NN captures_NNS as_IN much_JJ variability_NN as_IN possible_JJ with_IN a_DT
          linear_JJ combination_NN of_IN the_DT data_NNS and_CC is_VBZ uncorrelated_JJ with_IN
          all_DT other_JJ principal_JJ components_NNS ._. The_DT resulting_VBG data_NN points_NNS
          represent_VBP a_DT projection_NN of_IN the_DT dataset_NN ._. PCA_NNP was_VBD conducted_VBN
          on_IN all_DT three_CD datasets_NNS and_CC hence_RB there_EX were_VBD three_CD
          different_JJ input_NN variables_NNS ._. With_IN the_DT gene-expression-only_JJ
          dataset_NN ,_, we_PRP used_VBD the_NNP '_POS normalized_JJ '_POS gene_NN expression_NN data_NNS ,_,
          1_CD ,_, 040_CD genes_NNS ,_, for_IN all_DT rats_NNS ._. With_IN the_DT tissue-only_JJ dataset_NN ,_,
          we_PRP used_VBD the_DT data_NNS from_IN all_DT 11_CD tissue_NN metrics_NNS for_IN all_DT rats_NNS ._.
          Finally_RB for_IN the_DT combined_VBN dataset_NN for_IN each_DT rat_NN ,_, we_PRP
          combined_VBD the_DT tissue_NN metrics_NNS ,_, 11_CD metrics_NNS ,_, and_CC '_POS normalized_JJ '_POS
          gene-expression_JJ data_NNS (_( 1_CD ,_, 040_CD expression_NN values_NNS )_) to_TO give_VB a_DT
          total_NN of_IN 1_CD ,_, 051_CD measurements_NNS ,_, and_CC conducted_VBD PCA_NNP on_IN the_DT
          resulting_VBG dataset_NN ._.
          The_DT quadratic_JJ regression_NN classifier_NN [_NN 39_CD ]_NN is_VBZ given_VBN
          by_IN
          
          y_NN =_SYM 
          β_NN 
          0_CD +_NN 
          β_NN 
          1_CD (_( 
          e_SYM 
          1_CD -_: 
          1_LS )_) +_NN 
          β_NN 
          2_CD (_( 
          e_SYM 
          2_CD -_: 
          2_LS )_) +_NN 
          β_NN 
          3_CD (_( 
          e_SYM 
          2_CD -_: 
          2_LS )_) 2_CD +_NN 
          β_NN 
          4_CD (_( 
          e_SYM 
          2_CD -_: 
          2_LS )_) 2_CD +_NN 
          β_NN 
          5_CD (_( 
          e_SYM 
          1_CD -_: 
          1_LS )_) (_( 
          e_SYM 
          2_CD -_: 
          2_LS )_) +_NN 
          ε_NN 
          where_WRB 
          e_SYM 
          1_CD and_CC 
          e_SYM 
          2_CD are_VBP the_DT first_JJ and_CC second_JJ principal_JJ
          components_NNS respectively_RB and_CC 
          ε_NN is_VBZ assumed_VBN to_TO be_VB independently_RB
          and_CC identically_RB normally_RB distributed_VBN with_IN mean_NN 0_CD and_CC
          variance_NN 
          σ_NN 2_CD ._. Also_RB note_NN that_IN 
          1_CD and_CC 
          2_CD are_VBP the_DT arithmetic_NN means_NNS of_IN all_DT of_IN
          the_DT first_JJ and_CC second_JJ principal_JJ components_NNS ._. The_DT model_NN was_VBD
          estimated_VBN using_VBG the_DT usual_JJ least-squares_JJ assumptions_NNS ,_,
          where_WRB the_DT dependent_JJ variable_NN ,_, 
          y_NN ,_, was_VBD an_DT indicator_NN variable_JJ for_IN
          CCl_NNP 
          4_CD toxicity_NN ._.
          The_DT cross-validation_JJ probability_NN is_VBZ estimated_VBN by_IN first_JJ
          calculating_VBG the_DT first_JJ two_CD principal_JJ components_NNS of_IN the_NNP
          '_POS normalized_JJ '_POS data_NNS ,_, except_IN for_IN one_CD rat_NN ._. Using_VBG the_DT two_CD
          principal_JJ components_NNS and_CC the_DT CCl_NNP 
          4_CD -_: toxicity_NN classification_NN ,_, the_DT
          quadratic_JJ regression_NN classifier_NN was_VBD fit_VBN to_TO estimate_VB the_DT
          coefficients_NNS 
          β_NN 
          0_CD through_IN 
          β_NN 
          5_CD ._. Then_RB the_DT same_JJ eigenvectors_NNS ,_, or_CC
          projection_NN estimated_VBN in_IN the_DT PCA_NNP ,_, were_VBD applied_VBN to_TO the_DT
          left-out_JJ observation_NN to_TO estimate_VB the_DT first_JJ two_CD principal_JJ
          components_NNS ;_: note_NN that_IN this_DT side-steps_JJ any_DT potential_JJ
          prediction_NN bias_NN ._. The_DT principal_JJ components_NNS are_VBP then_RB
          plugged_VBD into_IN the_DT estimated_VBN quadratic_JJ regression_NN
          classifier_NN ._. If_IN the_DT resulting_VBG prediction_NN ,_, 
          y_NN ,_, was_VBD above_IN 0_CD ._. 5_CD ,_, then_RB the_DT sample_NN
          was_VBD classified_VBN as_IN suffering_VBG from_IN CCl_NNP 
          4_CD toxicity_NN ;_: if_IN the_DT value_NN was_VBD below_IN
          0_CD ._. 5_CD ,_, then_RB it_PRP was_VBD classified_VBN as_RB not_RB suffering_VBG from_IN CCl_NNP 
          4_CD toxicity_NN ._. To_TO estimate_VB the_DT accuracy_NN
          of_IN the_DT classification_NN ,_, this_DT was_VBD repeated_VBN so_IN that_IN every_DT
          rat_NN was_VBD left_VBN out_IN and_CC then_RB predicted_VBD ._.
          PCA_NNP ,_, Spearman_NNP 's_POS rank_NN correlations_NNS ,_, quadratic_JJ
          regression_NN classification_NN and_CC cross-validation_JJ were_VBD
          programmed_VBN in_IN MatLab_NNP release_NN 12_CD ._. Scripts_NNP are_VBP freely_RB
          available_JJ from_IN the_DT authors_NNS upon_IN request_NN ._.
        
      
      
        Additional_JJ data_NNS files_NNS
        An_DT Excel_NNP spreadsheet_NN showing_VBG genes_NNS correlating_VBG with_IN
        tissue_NN features_NNS (_( Additional_JJ data_NNS file_VBP 1_LS )_) ,_, also_RB represented_VBD
        in_IN 4_CD pdf_NN files_NNS that_WDT contain_VBP tables_NNS of_IN genes_NNS correlating_VBG
        with_IN %_NN clear_JJ space_NN (_( Additional_JJ data_NNS file_VBP 2_LS )_) ,_, area_NN %_NN
        vacuoles_NNS (_( Additional_JJ data_NNS file_VBP 3_LS )_) ,_, vacuoles_NNS /_NN mm_NN 2_CD (_( Additional_JJ
        data_NNS file_VBP 4_LS )_) ,_, and_CC all_DT other_JJ metrices_NNS (_( Additional_JJ data_NNS file_VBP
        5_LS )_) ._. These_DT tables_NNS include_VBP gene_NN descriptions_NNS for_IN the_DT ADME_NNP
        chip_NN [_NN 40_CD ]_NN ,_, updated_VBN with_IN descriptions_NNS provided_VBN by_IN
        GenBank_NNP ._. Genes_NNP found_VBD to_TO be_VB associated_VBN with_IN the_DT biology_NN of_IN
        CCl_NNP 
        4_CD toxicity_NN are_VBP highlighted_VBN ._.
        Additional_JJ data_NNS file_VBP 1_CD
        An_DT Excel_NNP spreadsheet_NN showing_VBG genes_NNS correlating_VBG with_IN
        tissue_NN features_NNS
        An_DT Excel_NNP spreadsheet_NN showing_VBG genes_NNS correlating_VBG with_IN
        tissue_NN features_NNS
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 2_CD
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN %_NN clear_JJ space_NN
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN %_NN clear_JJ space_NN
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 3_CD
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN area_NN %_NN vacuoles_NNS
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN area_NN %_NN vacuoles_NNS
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 4_CD
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN vacuoles_NNS /_NN mm_NN 2_CD
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN vacuoles_NNS /_NN mm_NN 2_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 5_CD
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN all_DT other_JJ metrices_NNS
        A_DT table_NN of_IN genes_NNS correlating_VBG with_IN all_DT other_JJ metrices_NNS
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
      
    
  
